✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Dipna Pharmachem Ltd.

DPL

Market Cap
₹25 Cr.
P/E
25.18

Dipna Pharmachem Ltd.

  • Dipna Pharma.
  • Deccan Health Care
  • EVOQ Remedies

FAQs on Dipna Pharmachem Ltd. Shareprice

Dipna Pharma. has given better returns compared to its competitors.
Dipna Pharma. has grown at ~-9.54% over the last 3yrs while peers have grown at a median rate of -11.03%

Dipna Pharma. is not expensive.
Latest PE of Dipna Pharma. is 25.18, while 3 year average PE is 27.84.
Also latest EV/EBITDA of Dipna Pharma. is 8.69 while 3yr average is 9.18.

View FAQ's On Business

Growth Table

  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • EVOQ Remedies

Balance Sheet

  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • EVOQ Remedies

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • EVOQ Remedies

Cash Flow

  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • EVOQ Remedies

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • EVOQ Remedies

Quarterly Results

  • Dipna Pharmachem Ltd.
  • Deccan Health Care
  • EVOQ Remedies

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Dipna Pharmachem Ltd. Financials

Dipna Pharma. balance sheet is weak and might have solvency issues

The net debt of Dipna Pharma. is decreasing.
Latest net debt of Dipna Pharma. is ₹13.1 Crs as of Sep-25.
This is less than Mar-25 when it was ₹16.77 Crs.

The profit is oscillating.
The profit of Dipna Pharma. is ₹1.75 Crs for TTM, ₹0.97 Crs for Mar 2025 and ₹1.09 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dipna Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech